{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T10:57:17Z","timestamp":1758279437571},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2016,6,30]],"date-time":"2016-06-30T00:00:00Z","timestamp":1467244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0157812","type":"journal-article","created":{"date-parts":[[2016,6,30]],"date-time":"2016-06-30T19:57:09Z","timestamp":1467316629000},"page":"e0157812","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Early Clinical Experience with a Polymer-Free Biolimus A9 Drug-Coated Stent in DES-Type Patients Who Are Poor Candidates for Prolonged Dual Anti-Platelet Therapy"],"prefix":"10.1371","volume":"11","author":[{"given":"Tim","family":"Kinnaird","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmood","family":"Butt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fairoz","family":"Abdul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaled","family":"Yazji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Hailan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Ossei-Gerning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Chase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anirban","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,6,30]]},"reference":[{"issue":"9281","key":"ref1","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"SR Mehta","year":"2001","journal-title":"Lancet"},{"issue":"23","key":"ref2","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents","volume":"371","author":"L Mauri","year":"2014","journal-title":"N Engl J Med"},{"issue":"21","key":"ref3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2008.04.002","article-title":"Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis","volume":"51","author":"EM Antman","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"ref4","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehr422","article-title":"Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial","volume":"32","author":"RC Becker","year":"2011","journal-title":"Eur Heart J"},{"issue":"16","key":"ref5","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.111.071589","article-title":"Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial","volume":"125","author":"M Valgimigli","year":"2012","journal-title":"Circulation"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehi731","article-title":"Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: results from the Euro Heart Survey on Coronary Revascularization","volume":"27","author":"M Hordijk-Trion","year":"2006","journal-title":"Eur Heart J"},{"issue":"17","key":"ref7","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehr126","article-title":"Evaluating the &apos;all-comers&apos; design: a comparison of participants in two &apos;all-comers&apos; PCI trials with non-participants","volume":"32","author":"SP de Boer","year":"2011","journal-title":"Eur Heart J"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","DOI":"10.1136\/hrt.2007.131284","article-title":"Bleeding during percutaneous intervention: tailoring the approach to minimise risk","volume":"95","author":"T Kinnaird","year":"2009","journal-title":"Heart"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2007.02.027","article-title":"Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial","volume":"49","author":"SV Manoukian","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"37","key":"ref10","article-title":"2014 ESC\/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)","volume":"35","author":"S Windecker","year":"2014","journal-title":"Eur Heart J"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcin.2015.09.008","article-title":"Polymer-Free Biolimus A9-Coated Stents in the Treatment of De Novo Coronary Lesions: 4- and 12-Month Angiographic Follow-Up and Final 5-Year Clinical Outcomes of the Prospective, Multicenter BioFreedom FIM Clinical Trial","volume":"9","author":"RA Costa","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"issue":"21","key":"ref12","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1503943","article-title":"Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk","volume":"373","author":"P Urban","year":"2015","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2011-300299","article-title":"British Cardiovascular Intervention Society Registry for audit and quality assessment of percutaneous coronary interventions in the United Kingdom","volume":"97","author":"PF Ludman","year":"2011","journal-title":"Heart"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.1016\/S0002-9149(03)00972-X","article-title":"Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions","volume":"92","author":"TD Kinnaird","year":"2003","journal-title":"Am J Cardiol"},{"issue":"23","key":"ref15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2009.09.076","article-title":"A risk score to predict bleeding in patients with acute coronary syndromes","volume":"55","author":"R Mehran","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","DOI":"10.1177\/2048872612453924","article-title":"Comparing the predictive validity of three contemporary bleeding risk scores in acute coronary syndrome","volume":"1","author":"E Abu-Assi","year":"2012","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"16","key":"ref17","article-title":"Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention","volume":"315","author":"RW Yeh","year":"2016","journal-title":"JAMA"},{"issue":"9872","key":"ref18","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(12)62177-1","article-title":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial","volume":"381","author":"WJ Dewilde","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjcard.2014.03.060","article-title":"Anticoagulant and antiplatelet therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention","volume":"114","author":"K Goto","year":"2014","journal-title":"Am J Cardiol"},{"issue":"10","key":"ref20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2012.11.049","article-title":"Why are we still using coronary bare-metal stents?","volume":"61","author":"MC Morice","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"ref21","first-page":"65","article-title":"Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates","author":"M Valgimigli","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"ref22","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.106.612812","article-title":"Adverse impact of bleeding on prognosis in patients with acute coronary syndromes","volume":"114","author":"JW Eikelboom","year":"2006","journal-title":"Circulation"},{"key":"ref23","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehu026","article-title":"Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantation","volume":"35","author":"S Silber","year":"2014","journal-title":"European Heart Journal"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","DOI":"10.1002\/ccd.24749","article-title":"Clinical outcomes in real-world patients with acute myocardial infarction receiving XIENCE V<sup>\u00ae<\/sup> everolimus-eluting stents: one-year results from the XIENCE V USA study","volume":"82","author":"K Sudhir","year":"2013","journal-title":"Catheter Cardiovasc Interv"},{"issue":"15","key":"ref25","article-title":"A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)","volume":"60","author":"BK Kim","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"ref26","article-title":"Three vs. twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial","volume":"310","author":"F Feres","year":"2013","journal-title":"JAMA"},{"issue":"3","key":"ref27","article-title":"Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience\/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study","volume":"125","author":"HC Gwon","year":"2012","journal-title":"Circulation"},{"key":"ref28","article-title":"Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","author":"G Giustino","year":"2015","journal-title":"JACC Forthcoming"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","DOI":"10.1002\/ccd.23407","article-title":"In vivo comparison of a polymer-free Biolimus A9-eluting stent with a biodegradable polymer-based Biolimus A9 eluting stent and a bare metal stent in balloon denuded and radiated hypercholesterolemic rabbit iliac arteries","volume":"80","author":"R Waksman","year":"2012","journal-title":"Catheter Cardiovasc Interv"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.109.877522","article-title":"Polymer-free biolimus a9-coated stent demonstrates more sustained intimal inhibition, improved healing, and reduced inflammation compared with a polymer-coated sirolimus-eluting cypher stent in a porcine model","volume":"3","author":"N Tada","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"ref31","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f6530","article-title":"Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis","volume":"347","author":"EP Navarese","year":"2013","journal-title":"BMJ"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0157812","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T01:14:28Z","timestamp":1718673268000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0157812"}},"subtitle":[],"editor":[{"given":"Kevin J.","family":"Croce","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,6,30]]},"references-count":31,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0157812","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,30]]}}}